Income Statement Tactile Systems Technology, Inc.
Equities
TCMD
US87357P1003
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.95 USD | +0.27% |
|
-1.85% | +3.22% |
| 01-05 | Tactile Systems Technology Shares Rise After Piper Sandler Upgrade | MT |
| 01-05 | Piper Sandler Upgrades Tactile Systems Technology to Overweight From Neutral, Adjusts Price Target to $35 From $20 | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 187M | 208M | 247M | 274M | 293M | |||||
Total Revenues | 187M | 208M | 247M | 274M | 293M | |||||
Cost of Goods Sold, Total | 53.92M | 59.84M | 70.81M | 79.29M | 76.3M | |||||
Gross Profit | 133M | 148M | 176M | 195M | 217M | |||||
Selling General & Admin Expenses, Total | 128M | 144M | 167M | 169M | 183M | |||||
R&D Expenses | 5.26M | 5.66M | 7.09M | 7.82M | 8.83M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | 739K | 2.58M | 2.55M | 2.53M | |||||
Other Operating Expenses, Total | 133M | 150M | 177M | 180M | 195M | |||||
Operating Income | 397K | -1.76M | -908K | 15.57M | 22.18M | |||||
Interest Expense, Total | - | -531K | -2.72M | - | -2.08M | |||||
Interest And Investment Income | 167K | - | - | - | 3.38M | |||||
Net Interest Expenses | 167K | -531K | -2.72M | - | 1.3M | |||||
Other Non Operating Income (Expenses) | - | - | - | -2.27M | 9K | |||||
EBT, Excl. Unusual Items | 564K | -2.29M | -3.62M | 13.3M | 23.49M | |||||
Restructuring Charges | -4.02M | - | - | - | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Other Unusual Items | 1.2M | - | -11.85M | 2.48M | - | |||||
EBT, Incl. Unusual Items | -2.26M | -2.29M | -15.47M | 15.77M | 23.49M | |||||
Income Tax Expense | -1.64M | 9.52M | 2.39M | -12.74M | 6.53M | |||||
Earnings From Continuing Operations | -620K | -11.81M | -17.87M | 28.52M | 16.96M | |||||
Net Income to Company | -620K | -11.81M | -17.87M | 28.52M | 16.96M | |||||
Net Income - (IS) | -620K | -11.81M | -17.87M | 28.52M | 16.96M | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | -620K | -11.81M | -17.87M | 28.52M | 16.96M | |||||
Net Income to Common Excl. Extra Items | -620K | -11.81M | -17.87M | 28.52M | 16.96M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.03 | -0.6 | -0.89 | 1.24 | 0.71 | |||||
Basic EPS - Continuing Operations | -0.03 | -0.6 | -0.89 | 1.24 | 0.71 | |||||
Basic Weighted Average Shares Outstanding | 19.35M | 19.72M | 20.07M | 22.93M | 23.88M | |||||
Net EPS - Diluted | -0.03 | -0.6 | -0.89 | 1.23 | 0.7 | |||||
Diluted EPS - Continuing Operations | -0.03 | -0.6 | -0.89 | 1.23 | 0.7 | |||||
Diluted Weighted Average Shares Outstanding | 19.35M | 19.72M | 20.07M | 23.18M | 24.14M | |||||
Normalized Basic EPS | 0.02 | -0.07 | -0.11 | 0.36 | 0.61 | |||||
Normalized Diluted EPS | 0.02 | -0.07 | -0.11 | 0.36 | 0.61 | |||||
Payout Ratio | - | - | - | - | - | |||||
Supplemental Items | ||||||||||
EBITDA | 3.19M | 1.55M | 5.36M | 22.1M | 28.97M | |||||
EBITA | 797K | -730K | 2.89M | 19.37M | 25.98M | |||||
EBIT | 397K | -1.76M | -908K | 15.57M | 22.18M | |||||
EBITDAR | 6.19M | 5.15M | 9.16M | 25.7M | 32.47M | |||||
Total Revenues (As Reported) | 187M | 208M | 247M | 274M | 293M | |||||
Effective Tax Rate - (Ratio) | 72.58 | -415.09 | -15.47 | -80.82 | 27.8 | |||||
Current Domestic Taxes | -359K | -1.06M | 2.48M | 6.48M | 5.67M | |||||
Total Current Taxes | -359K | -1.06M | 2.48M | 6.48M | 5.67M | |||||
Deferred Domestic Taxes | -1.23M | 10.23M | -32K | -19.38M | 1.07M | |||||
Total Deferred Taxes | -1.23M | 10.23M | -32K | -19.38M | 1.07M | |||||
Normalized Net Income | 352K | -1.43M | -2.26M | 8.31M | 14.68M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 100K | 100K | 100K | 100K | - | |||||
Selling and Marketing Expenses | 79.63M | 86.78M | 106M | 107M | 112M | |||||
Research And Development Expense From Footnotes | 5.26M | 5.66M | 7.09M | 7.82M | 8.83M | |||||
Net Rental Expense, Total | 3M | 3.6M | 3.8M | 3.6M | 3.5M | |||||
Imputed Operating Lease Interest Expense | - | 300K | 1.08M | - | 1.22M | |||||
Imputed Operating Lease Depreciation | - | 3.3M | 2.72M | - | 2.28M | |||||
Stock-Based Comp., COGS (Total) | 539K | 433K | 367K | 420K | 365K | |||||
Stock-Based Comp., R&D Exp. (Total) | 360K | 314K | 226K | 133K | 157K | |||||
Stock-Based Comp., S&M Exp. (Total) | 5.06M | 4.07M | 4.06M | 2.98M | 2.41M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 4.73M | 5.36M | 4.95M | 4.01M | 4.88M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 10.69M | 10.17M | 9.6M | 7.55M | 7.82M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















